Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Registration Number
- NCT01226966
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3152
Inclusion Criteria
- Patients diagnosed with type 2 diabetes
- Patients having recently started (for less than one week) or starting liraglutide (Victoza®) treatment
Exclusion Criteria
- Hypersensitivity (allergy) to liraglutide or to any of the excipients
- Patient is participating in a clinical trial at the inclusion
- Type 1 diabetes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description A liraglutide -
- Primary Outcome Measures
Name Time Method Percentage of patients still in liraglutide treatment and having a HbA1c (glycosylated haemoglobin) value below 7.0% Month 24
- Secondary Outcome Measures
Name Time Method Change in Body Weight at Month 18 Month 0, Month 18 Change in HbA1c at month 6 Month 0, Month 6 Change in HbA1c at month 3 Month 0, Month 3 Change in HbA1c at month 12 Month 0, Month 12 Change in fasting plasma glucose (FPG) at month 12 Month 0, Month 12 Change in Body Weight at Month 3 Month 0, Month 3 Change in Body Weight at Month 24 Month 0, Month 24 Change in HbA1c at month 24 Month 0, Month 24 Change in fasting plasma glucose (FPG) at month 3 Month 0, Month 3 Change in fasting plasma glucose (FPG) at month 6 Month 0, Month 6 Change in fasting plasma glucose (FPG) at month 18 Month 0, Month 18 Change in HbA1c at month 18 Month 0, Month 18 Change in fasting plasma glucose (FPG) at month 24 Month 0, Month 24 Change in Body Weight at Month 12 Month 0, Month 12 Change in Body Weight at Month 6 Month 0, Month 6
Trial Locations
- Locations (1)
Novo Nordisk Investigational Site
🇫🇷Paris La défense cedex, France